Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 35, Issue 5, 2005, Pages 489-495

  Kim, J G ^a   Sohn, S K ^a   Kim, D H ^a   Baek, J H ^a   Lee, K B ^a   Min, W S ^b   Kim, C C ^b   Lee, M H ^c   Lee, J J ^d   Chung, I J ^d   Kim, H J ^d   Lee, J W ^b  

^a Kyungpook National University Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Chonnam National University Medical School   (South Korea)

Author keywords

ABO; Allogeneic; Incompatibility; Outcome; PBSCT

Indexed keywords

ACICLOVIR; BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; METHOTREXATE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DONOR; ERYTHROCYTE; FEMALE; FOLLOW UP; GRAFT FAILURE; HEMATOLOGIC DISEASE; HEMOLYSIS; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION PREVENTION; KOREA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OUTCOMES RESEARCH; PRIORITY JOURNAL; PURE RED CELL ANEMIA; SIBLING; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BLOOD GROUP INCOMPATIBILITY; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; KINETICS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIBLINGS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 20144371051     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704816     Document Type: Article

References (24)

1. Buckner CD, Clift RA, Sanders JE et al. ABO-incompatible marrow transplants. Transplantation 1978; 26 233-238.
2. Bensinger WI, Buchner CD, Thomas ED, Clift RA. ABO-incompatible marrow transplants. Transplantation 1982; 33 427-429.
3. Hershko C, Gale RP, HO W, Fitchen J. ABH antigens and bone marrow transplantation. Br J Haematol 1980; 44: 65-73.
4. Kalaycioglu M, Copelan E, Avalos B et al. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 1995; 15: 105-110.
5. Petz LD. Hemolysis associated with transplantation. Transfusion 1998; 38: 224-228.
6. Benjamin RJ, McGurk S, Ralston MS et al. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999; 39: 179-187.
7. Stussi G, Seebach L, Muntwyler J et al. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br J Haematol 2001; 113: 251-253.
8. Stussi G, Muntwyler J, Passweg JR et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 30: 87-93.
9. Bacigalupo A, Van Lint MT, Occhini D et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988; 45: 1091-1094.
10. Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175-181.
11. Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95: 3702-3709.
12. Bornhauser M, Ordemann R, Paaz U et al. Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis. Bone Marrow Transplant 1997; 19: 295-297.
13. Oziel-Taieb S, Faucher-Barbey C, Chabannon C et al. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant 1997; 19: 1155-1156.
14. Sohn SK, Kim JG, Seo KW et al. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2002; 30 81-86.
15. Sohn SK, Kim JG, Sung WJ et al. Harvesting peripheral blood stem cells from healthy donors on 4th day of cytokine mobilization. J Clin Apher 2003; 18: 186-189.
16. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
17. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
18. Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma effect. Blood 2000; 96: 1150-1156.
19. Rowley SD, Liang PS, Ulz L. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant 2000; 26: 749-757.
20. Szulman AE. The histological distribution of blood group substances A and B in man. J Exp Med 1960; 111: 785-799.
21. Salmon JP, Michaux S, Hermanne JP et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 1999; 39: 824-827.
22. Bolan CD, Childs RW, Procter JL et al. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 2001; 112: 787-795.
23. Worel N, Kalhs P, Keil F et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 2003; 43: 1153-1161.
24. Lane TA, Ho AD, Bashey A et al. Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage and granulocyte-colony-stimulating factors. Transfusion 1999; 39: 39-47.